Tuberculosis is a disease caused by Mycobacterium tuberculosis, with high mortality rates and an extended treatment that causes severe adverse effects, besides the emergence of resistant bacteria. Therefore, the search for new compounds with anti-M. tuberculosis activity has considerably increased in recent years. In this context, benzohydrazones are significant compounds that have antifungal and antibacterial action. This study aimed at evaluating the in vitro activity of 18 benzohydrazones against M. tuberculosis. Compounds' cytotoxicity, inhibition of M. tuberculosis efflux pumps, and in silico absorption, distribution, metabolism, excretion, and toxicity (ADMET) assays were also performed. In general, the minimum inhibitory concentration values for the standard M. tuberculosis H37Rv strain ranged from 7.8 to 250 μg/mL, and some compounds were not toxic to any of the cells tested (IC50 ranged from 18.0 to 302.5 μg/mL). In addition, compounds (4) and (7) showed to be possible efflux pump inhibitors. In ADMET assays, all benzohydrazones had high gastrointestinal absorption. Most of the compounds were able to overcome the blood–brain barrier, and no compounds had irritant or tumorigenic effects. Compounds (1), (3), (9), (12), and (15) stood out for showing good activities, both in vitro and in silico assays.
RodriguesL., ParishT., BalganeshM., and AinsaJ.A.. 2017. Antituberculosis drugs: reducing efflux = increasing activity. Drug Disc. Today. 22:592–599.
3.
WangZ., ZhiF., WangR., et al.2013. Synthesis, crystal structures and antibacterial activities of benzohydrazone derivatives from 4-diethylaminosalicylaldehyde. J. Chil. Chem. Soc. 58:1763–1766.
4.
RajK.K.V., NarayanaB., AshalathaB.V, KumariN.S, and SarojiniB.K.. 2007. Synthesis of some bioactive 2-bromo-5-methoxy-N’-[4-(aryl)-1,3-thiazol-2-yl]benzohydrazide derivatives. Eur. J. Med. Chem. 42:427–429.
5.
SampironE.G., CostacurtaG.F, BaldinV.P, et al.2019. Hydrazone, benzohydrazones and isoniazid-acylhydrazones as potential antituberculosis agents. Future Microbiol. 14:981–994.
6.
VogelA.I., FurnisB.S, HannafordA.J, SmithT.W.G, and TatchellA.R.. 1989. Vogel's Textbook of Practical Organic Chemistry, 5th ed. Longman Scientific and Technical, London, UK.
7.
TajudeenS.S., and KannappanG.. 2013. Synthetic, structural and pharmacological studies on some isonicotinohydrazide and benzohydrazide analogues. J. Pharm. Res. 7:534–539.
8.
LiuY., KongW., YangZ., DaiM., ShiL., and GuoD.. 2016. Synthesis and fluorescence properties of Eu 3+, Tb 3+ complexes with Schiff base derivatives. J. Fluoresce. 26:567–576.
9.
PouralimardanO., CharnayouA.C, JaniakC., and MonfaredH.H.. 2007. Hydrazone Schiff base-manganese (II) complexes: synthesis, crystal structure and catalytic reactivity. Inorg. Chim. Acta. 360:1599–1608.
10.
ManikandanV., BalajiS., SenbagamR., et al.2016. Synthesis, spectral LFER and antimicrobial activities of some (E)-N׳-(1-(substituted phenyl)ethylidene)benzohydrazides. Annales. 71:1–30.
11.
OkimotoM., and ChibaT.. 1990. Electrochemical oxidation of ketone acylhydrazones and their hydrogen cyanide adducts in sodium cyanide-methanol. Transformation of ketones to nitriles. J. Org. Chem. 55:1070–1076.
12.
YoussefA.S.A., HemdanM.M, EmaraS.A, and KamelR.M.. 2015. Action of Hydrazines on 2-(2-Oxindolin-3-ylidene) malononitrile,(E, Z)-Ethyl 2-cyano-2-(2-oxindolin-3-ylidene) acetate and Isatin-β-thiosemicarbazone as a Source of Spiro Indoline-pyrazole Systems. J. Heterocycl. Chem. 52:1331–1336.
13.
PalominoJ., MartinA., CamachoM., GuerraH., SwingsJ., and PortaelsF.. 2002. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 46:2720–2722.
14.
Clinical and Laboratory Standards Institute (CLSI). 2015. M07-A10: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—10th Ed. CLSI, Wayne, PA.
15.
PapazisisK.T., GeromichalosG.D, DimitriadisK.A, and KortsarisA.H.. 1997. Optimization of the sulforhodamine B colorimetric assay. J. Immunol. Methods. 208:151–158.
16.
MosmannT.1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:55–63.
17.
RodriguesL., VillellasC., BailoR., ViveirosM., and AinsaJ.A.. 2013. Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis Antimicrob. Agents. Chemother. 57:751–757.
18.
DainaA., MichielinO., and ZoetelV.. 2017. SwissADME: a free web tool to evaluate pharmacokinetics, druglikeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7:42717.
19.
SanderT., FreyssJ., KorffM., ReichJ.R, and RufenerC.. 2009. OSIRIS, an entirely in-house developed drug discovery informatics system. J. Chem. Inf. Model. 49:232–246.
20.
ChengF., LiW., ZhouY., et al.2012. AdmetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J. Chem. Inf. Mod. 52:3099–3105.
21.
QuanD., NagalingamG., PayneR., and TriccasJ.A.. 2017. New tuberculosis drug leads from naturally occurring compounds. Int. J. Infect. Dis. 56:212–220.
22.
SouzaM.R.P., CoelhoN.P, BaldinV.P, et al.2018. Synthesis of novel (-)-Camphene-based thiosemicarbazones and evaluation of anti-Mycobacterium tuberculosis activity. Nat. Prod. Res. 33:3372–3377.
23.
PeramanR., TiwariA.K, VaniM.G, et al.2018. New camphor hybrids: lipophilic enhancement improves antimicrobial efficacy against drug-resistant pathogenic microbes and intestinal worms. Med. Chem. Res. 27:1728–1739.
24.
Lopes-OrtizM.A., PaniceM.R, MeloE.B, et al.2020. Synthesis and anti-Mycobacterium tuberculosis activity of imide-β-carboline and carbomethoxy-β-carboline derivatives. Eur. J. Med. Chem. 187:111935.
25.
AngelovaV.T., ValchevaV., VassilevN.G, et al.2016. Antimycobacterial activity of novel hydrazide-hydrazone derivatives with 2H-chromene and coumarin scaffold. Bioorg. Med. Chem. Lett. 27:223–227.
26.
BhaleraoM.B., DhumalS.T, DeshmukhA.R, et al.2016. New bithiazolyl hydrazones: novel synthesis, characterization and antitubercular evaluation. Bioorg. Med. Chem. Lett. 27:288–294.
27.
MatsumotoY., KinjoT., MotookaD., et al.2019. Comprehensive subspecies identification of 175 nontuberculous mycobacteria species based on 7547 genomic profiles. Emerg. Microbes Infect. 8:1043–1053.
28.
ShahrakiA.H., HeidariehP., BostanabadS.Z, et al.2015. “Multidrug-resistant tuberculosis” may be nontuberculous mycobacteria. Eur. J. Intern. Med. 26:279–284.
29.
WeledjiE.P., WeledjiE.K, AssobJ.C, and NsaghaD.S.. 2017. Pros, cons and future of antibiotics. New Horiz. Transl. Med. 4:9–14.
30.
RissT., NilesA., MoravecR., KarassinaN., and VidugirieneJ.. 2019. Assay Guidance Manual—Cytotoxicity Assays: In Vitro Methods to Measure Dead Cells. Bethesda, MD.
31.
ZuccoF., De AngelisI., TestaiE., and StammatiA.. 2004. Toxicology investigations with cell culture systems: 20 years after. Toxicol. In Vitro. 18:153–163.
32.
OrmeI.2001. Search for new drugs for treatment of tuberculosis. Antimicrob. Agents Chemother. 45:1943–1946.
33.
WangX.L., ZhangY.B, TangJ.F, et al.2012. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Eur. J. Med. Chem. 57:373–382.
34.
ViveirosM., MartinsM., RodriguesL., et al.2012. Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs. Expert Rev. Anti Infect. Ther. 10:983–998.
35.
CostacurtaG.F., SouzaM.R.P, SampironE.G, et al.2020. Synthesis and biological evaluation of 12 novel (-)-camphene-based 1,3,4-thiadiazoles against Mycobacterium tuberculosis. Future Microbiol. 15:723–738.
36.
ButinaD., SegallM.D, and FrankcombeK.. 2002. Predicting ADME properties in silico: methods and models. Drug Discov. Today. 7:583–588.
37.
LipinskiC.A., LombardoF., DominyB.W, and FeeneyP.J.. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46:3–26.
38.
MoriguchiI., ShuichiH., LiuQ., and NakagomeI., MatsushitaY.. 1992. Simple method of calculating octanol/water partition coefficient. Chem. Pharm. Bull. 40:127–130.
39.
WangN.N., DongJ., DengY.H, et al.2016. ADME properties evaluation in drug discovery: prediction of Caco-2 cell permeability using a combination of NSGA-II and boosting. J. Chem. Inf. Model. 56:763–773.
BhattM.A., and Al-OmarM.A.. 2013. Synthesis, characterization, and in vitro anti-Mycobacterium tuberculosis activity of terpene Schiff bases. Med. Chem. Res. 22:4522–4528.
42.
DainaA., MichielinO., and ZoeteV.. 2014. iLOGP: a simple, robust, and efficient description of noctanol/water partition coefficient for drug design using the GB/SA approach. J. Chem. Inf. Model. 54:3284–3301.
